Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04459715 |
|---|---|
| Brief Title: | A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX) |
| First Submitted : | June 30, 2020 |
| First Submitted that Met QC Criteria : | July 3, 2020 |
| First Posted : | July 7, 2020 |
| Last Update Submitted that Met QC Criteria : | November 17, 2022 |
| Last Update Posted : | November 22, 2022 |